Nitric oxide modulates bone anabolism through regulation of osteoblast glycolysis and differentiation

Area of Science:

• Biochemistry
• Bone Biology
• Metabolic Pathways

Background:

• Nitric oxide (NO) shows potential in preventing bone loss and fractures in preclinical models.
• The precise mechanisms of NO's role in bone anabolism are not fully understood.
• Argininosuccinate lyase (ASL) is crucial for arginine synthesis and nitric oxide synthase (NOS)-dependent NO production.

Purpose of the Study:

• To investigate the role of ASL deficiency (ASLD) in NO production and osteoblast function.
• To elucidate the mechanisms linking NO, glycolysis, and osteoblast differentiation.
• To assess the therapeutic potential of modulating NO synthesis for bone health.

Main Methods:

• Utilized a hypomorphic mouse model of ASLD.
• Investigated the impact of ASL deficiency on NO production, osteoblast differentiation, and glycolysis.
• Examined the effect of heterozygous caveolin 1 deletion on bone phenotype in ASLD mice.
• Studied induced pluripotent stem cells from an individual with ASLD.

Main Results:

• ASL deficiency led to reduced NO production and impaired osteoblast differentiation.
• Loss of NO-mediated glycolysis activation in osteoblasts contributed to the bone phenotype.
• Restoration of NO production via caveolin 1 deletion improved osteoblast function and bone mass.
• Findings were corroborated in human ASLD-derived stem cells.

Conclusions:

• ASL deficiency serves as a model for studying NO-dependent osteoblast function.
• The NO/glycolysis pathway is identified as a key regulator of osteoblast anabolism.
• Targeting the NO/glycolysis pathway presents a novel therapeutic strategy for enhancing bone formation.